Shanta Gold Limited
08 January 2007
For immediate release
SHANTA GOLD LIMITED
("Shanta Gold" or the "Company")
Shanta confirms that on 4 January 2007 the directors of the Company approved an
allotment of shares following the exercise of warrants over ordinary shares of
0.01p in the share capital of the Company (the "Warrants") as set out below:
Registered Holder Number of Subscription No. Of shares Subscription Value
Warrants Price
Hero Nominees Limited 44,000 30p 44,000 £13,200.00
Application will be made for the ordinary shares created pursuant to the
exercise of the Warrants (the "New Ordinary Shares") to be admitted to AIM and
dealings in the New Ordinary Shares is expected to commence on 12 January 2007.
The total number of issued ordinary shares in the Company, including the New
Ordinary Shares, is now 96,750,711 ordinary shares.
For further information contact:
David Youngman, W.H. Ireland Ltd. Tel: +44 (0) 161 832 6644
Walter Vorwerk, Shanta Gold Ltd Tel: +27 (0) 83 308 0080
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.